Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_assertion type Assertion NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_head.
- NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_assertion description "[These findings highlight the particular cell-specific activation profile of RET/GFRalpha3 and MET in MLS, and the close correlation between AKT activation and the round cell variant, thus opening up new therapeutic perspectives for MET/AKT inhibitors and antagonistic small molecules binding GFRalpha3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_provenance.
- NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_assertion evidence source_evidence_literature NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_provenance.
- NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_assertion SIO_000772 20522586 NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_provenance.
- NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_assertion wasDerivedFrom befree-20150227 NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_provenance.
- NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_assertion wasGeneratedBy ECO_0000203 NP802987.RAfwFN2WArBNbi-bCo41obeqG8z5mNsMyKp6c_jO3AqvQ130_provenance.